A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1994
10/13/1994	WO1994022876A1 Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial
10/13/1994	WO1994022875A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
10/13/1994	WO1994022873A1 Diamine salts of clavulanic acid
10/13/1994	WO1994022871A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS
10/13/1994	WO1994022869A1 FURO[3,2-b]PYRIDINES AND THIENO[3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
10/13/1994	WO1994022868A1 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
10/13/1994	WO1994022867A1 Bicyclic ansamycins and their use as antitumor agents
10/13/1994	WO1994022865A1 Imidazoloquinoxalinone derivatives as eaa antagonists
10/13/1994	WO1994022864A1 Acyclic nucleoside analogs and oligonucleotide sequences containing them
10/13/1994	WO1994022863A1 Second messenger cell signaling inhibitors
10/13/1994	WO1994022862A1 Indolizine derivative
10/13/1994	WO1994022861A1 PYRIDO[2,3-b][1,4]BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
10/13/1994	WO1994022858A1 Tetracyclic compounds as dopamine agonists
10/13/1994	WO1994022856A1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
10/13/1994	WO1994022852A1 Quinolines as type iv phosphodiesterase inhibitors
10/13/1994	WO1994022849A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation
10/13/1994	WO1994022845A1 Benzothiazole compound, process for producing the same, and use thereof
10/13/1994	WO1994022843A1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
10/13/1994	WO1994022842A1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
10/13/1994	WO1994022839A1 Antipsychotic benzimidazole derivatives
10/13/1994	WO1994022835A2 Heterocyclic compounds as platelet aggregation inhibitors
10/13/1994	WO1994022834A1 Heterocyclic derivatives as platelet aggregation inhibitors
10/13/1994	WO1994022832A1 (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament
10/13/1994	WO1994022831A1 (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament
10/13/1994	WO1994022827A1 3-phenyl-1,2,5,6-tetrahydropyridine derivatives as sedatives
10/13/1994	WO1994022825A1 Fibrinogen receptor antagonists
10/13/1994	WO1994022823A1 4-arylisoindole analgesics
10/13/1994	WO1994022822A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
10/13/1994	WO1994022821A1 Indole derivatives as testosterone 5 alpha-reductase inhibitors
10/13/1994	WO1994022820A1 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
10/13/1994	WO1994022814A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
10/13/1994	WO1994022809A1 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents
10/13/1994	WO1994022808A1 Substituted (arylalkoxybenzyl)aminopropanamide derivatives, their preparation and use as anti-epileptic, neuroprotective and antidepressant agents
10/13/1994	WO1994022807A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
10/13/1994	WO1994022806A1 Physiologicaly active substance res-1149-1 and derivative thereof
10/13/1994	WO1994022488A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION
10/13/1994	WO1994022486A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
10/13/1994	WO1994022483A2 Prodrugs with enhanced penetration into cells
10/13/1994	WO1994022481A1 Active-substance patch for releasing estradiol to the skin
10/13/1994	WO1994022480A1 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids
10/13/1994	WO1994022468A1 Method for delivering beneficial compositions to hair follicles
10/13/1994	WO1994022464A1 Urokinase plasminogen activator fragments
10/13/1994	WO1994022463A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
10/13/1994	WO1994022462A1 Anti-aids immunomodulator complex
10/13/1994	WO1994022457A1 Method and composition for treatment of osteoporosis
10/13/1994	WO1994022455A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	WO1994022453A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
10/13/1994	WO1994022452A1 Inhibition of anoxia or hypoxia-induced endothelium-mediated vasospasm with avermectins
10/13/1994	WO1994022451A1 Selective regulation of b lymphocyte precursors by hormones
10/13/1994	WO1994022450A1 Nasal pharmaceutical composition containing a progestational agent
10/13/1994	WO1994022448A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
10/13/1994	WO1994022447A1 Imidazolo-quinoxalinones for treating diseases of the central nervous system
10/13/1994	WO1994022446A1 Pharmaceutical composition for the prevention of neuronal cell death
10/13/1994	WO1994022445A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
10/13/1994	WO1994022443A1 Method for treating kawasaki syndrome
10/13/1994	WO1994022442A1 Heart failure remedy
10/13/1994	WO1994022441A2 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
10/13/1994	WO1994022439A1 Oral glutamine to reduce stomatitis
10/13/1994	WO1994022437A2 Method for treating amyloidosis
10/13/1994	WO1994022436A1 A method for treating abnormal cardiac contraction
10/13/1994	WO1994022435A1 A new composition containing selegiline
10/13/1994	WO1994022434A1 RETARDED-ACTION MICROTABLET MADE OF β-PHENYLPROPIOPHENONE DERIVATIVES
10/13/1994	WO1994022433A1 Broiler ascites preventive and method of preventing ascites
10/13/1994	WO1994022431A1 Controlled release preparation containing a salt of morphine
10/13/1994	WO1994022430A1 Method of producing liposomes
10/13/1994	WO1994022428A1 Method for reducing the induction of viruses using topically applied antioxidants
10/13/1994	WO1994022426A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994	WO1994022425A1 Anti-oxidant alkylaryl polyether alcohol polymers
10/13/1994	WO1994022422A1 Lidocaine aerosol anaesthetic
10/13/1994	WO1994022413A2 Triazole substituted quinoline derivatives
10/13/1994	WO1994022312A1 Method and composition for treatment of osteoporosis
10/13/1994	WO1994022309A1 Synthetic matrix metalloprotease inhibitors and uses thereof
10/13/1994	WO1994022307A1 Suppresion of hiv expression by organic thiophosphate
10/13/1994	WO1994022306A1 Nitric oxide combination therapy
10/13/1994	WO1994021240A3 Superparamagnetic particles, process for producing the same and their use
10/13/1994	WO1994020459A3 Pyrrolo-pyridine derivatives as dopamine receptor ligands
10/13/1994	CA2160139A1 Synthetic matrix metalloprotease inhibitors and uses thereof
10/13/1994	CA2159916A1 Targeted delivery of genes encoding antisense polyribonucleotides
10/13/1994	CA2159815A1 M2 receptor ligand for the treatment of neurological disorders
10/13/1994	CA2159723A1 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
10/13/1994	CA2159717A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	CA2159649A1 Anticoagulant compounds
10/13/1994	CA2159637A1 Urokinase plasminogen activator fragments
10/13/1994	CA2159632A1 Novel 5'-substituted nucleosides and oligomers produced therefrom
10/13/1994	CA2159631A1 Acyclic nucleoside analogs and oligonucleotide sequences containing them
10/13/1994	CA2159630A1 7-deazapurine modified oligonucleotides
10/13/1994	CA2159629A1 Oligonucleotides with amide linkages replacing phosphodiester linkages
10/13/1994	CA2159628A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
10/13/1994	CA2159482A1 Fibrinogen receptor antagonists
10/13/1994	CA2159447A1 Use of cis-or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
10/13/1994	CA2159443A1 Lymphocyte activating agent
10/13/1994	CA2159354A1 Method and composition for treatment of osteoporosis
10/13/1994	CA2159350A1 Modified oligonucleotides having improved anti-influenza activity
10/13/1994	CA2159220A1 Antipsychotic benzimidazole derivatives
10/13/1994	CA2159219A1 Cholestasis ameliorant
10/13/1994	CA2159209A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994	CA2159072A1 Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors
10/13/1994	CA2159070A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
10/13/1994	CA2158968A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation
10/13/1994	CA2158951A1 Nasale pharmaceutical composition containing a progestagenic agent

1 ... 7074 7075 7076 7077 7078 7079 7080 7081 7082 7083 7084 7085 7086 7087 7088 7089 7090 7091 7092 7093 7094 ... 7860